new studies on glp 1 The risk in patients taking GLP-1 drugs for obesity or diabetes is higher than with other diabetes drugs, suggest GLP-1 agonists' safety during pregnancy

Surgery offers greater weight loss and health benefits, but is invasive

Heres a link to a past post about a study that showed that bariatric surgery is more cost effective than GLP-1 drugs for obesity treatment

For a 250-pound person with 35% body fat, lean body mass is approximately 162 pounds, making the protein target 113 to 162 grams daily

Appetite can become more unpredictable

Exendin-9 administered IP was unable to block this effect, indicating a dominant role for CNS GLP-1R populations (77)

When stressed, the body produces cortisol which, if chronically elevated, can promote weight gain (especially around the belly) and also stimulate appetite for high-calorie comfort foods